Showing results (181-190 of 281) with videos related to

Sort By:
Pageof 29
The New England Journal of Medicine|September 3, 2013
Alogliptin after acute coronary syndrome in patients with type 2 diabetesWilliam B White, Christopher P Cannon, Simon R Heller, et al.
Hypertension (Dallas, Tex. : 1979)|February 1, 2021
The Benefits of Intensive Versus Standard Blood Pressure Treatment According to Fine Particulate Matter Air Pollution Exposure: A Post Hoc Analysis of SPRINTSadeer G Al-Kindi, Robert D Brook, Udayan Bhatt, et al.
The American Journal of the Medical Sciences|June 17, 2005
Addressing the global cardiovascular risk of hypertension, dyslipidemia, and insulin resistance in the southeastern United StatesMark C Houston, Jan Basile, William H Bestermann, et al.
Diabetes Care|June 12, 2016
Cardiovascular Mortality in Patients With Type 2 Diabetes and Recent Acute Coronary Syndromes From the EXAMINE TrialWilliam B White, Stuart Kupfer, Faiez Zannad, et al.
Diabetes, Obesity & Metabolism|January 7, 2017
Relationship of glycated haemoglobin and reported hypoglycaemia to cardiovascular outcomes in patients with type 2 diabetes and recent acute coronary syndrome events: The EXAMINE trialSimon R Heller, Richard M Bergenstal, William B White, et al.
Hypertension (Dallas, Tex. : 1979)|May 2, 2018
Impact of Intensive Versus Standard Blood Pressure Management by Tertiles of Blood Pressure in SPRINT (Systolic Blood Pressure Intervention Trial)Brian P Shapiro, Walter T Ambrosius, Joseph L Blackshear, et al.
Diabetes Care|November 15, 2007
Metabolic and clinical outcomes in nondiabetic individuals with the metabolic syndrome assigned to chlorthalidone, amlodipine, or lisinopril as initial treatment for hypertension: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)Henry R Black, Barry Davis, Joshua Barzilay, et al.
Hypertension (Dallas, Tex. : 1979)|February 24, 2001
Baseline Characteristics of Participants in the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)Richard H. Grimm, Karen L. Margolis, Vasilios Papademetriou, et al.
Diabetes, Obesity & Metabolism|October 13, 2017
Influence of metabolic syndrome and race on the relationship between intensive blood pressure control and cardiovascular outcomes in the SPRINT cohortKathleen Dungan, Timothy E Craven, Kyaw Soe, et al.
Archives of Internal Medicine|November 15, 2006
Fasting glucose levels and incident diabetes mellitus in older nondiabetic adults randomized to receive 3 different classes of antihypertensive treatment: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)Joshua I Barzilay, Barry R Davis, Jeffrey A Cutler, et al.
Pageof 29